AKT1 and prostate cancer: LncRNA MIR4435‐2HG repressed the FAK/AKT/β‐catenin signaling pathway by binding ST8SIA1, thereby mediating the growth and activity of prostate cancer cells, as confirmed by Xing et al [18].